Topics

Glioblastoma | Treatment | Clinical trials | Tumor-infiltrating lymphocytes

Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Tumor-infiltrating lymphocytes

1999

AA

Quattrocchi KB, Miller CH, Cush S, Bernard SA, Dull ST, Smith M, Gudeman S, Varia MA.
Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas.
J Neurooncol. 1999 Nov;45(2):141-57. doi: 10.1023/a:1006293606710. PMID: 10778730. Trial registration ID: NA. ˍ

2002

ME

Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ, Topalian SL, Sherry R, Restifo NP, Hubicki AM, Robinson MR, Raffeld M, Duray P, Seipp CA, Rogers-Freezer L, Morton KE, Mavroukakis SA, White DE, Rosenberg SA.
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.
Science. 2002 Sep 19;298(5594):850-4. doi: 10.1126/science.1076514. PMID: 12242449. Trial registration ID: NA. ˍ

2025

Chen Y, Ma X, Cheng Y, Zhuang W, Jin H, Lan Q.
536 Phase 1 trial of tumor-infiltrating lymphocyte (TIL) therapy in recurrent glioblastoma: A single-center experience using cells derived from primary surgical specimens [abstract].
J Immunother Cancer. 2025 Nov 4;13(Suppl 2):536. Trial registration ID: NCT04943913. ˍ